Found: 80
Select item for more details and to access through your institution.
Panitumumab w leczeniu chorych na raka jelita grubego.
- Published in:
- Gastroenterologia Kliniczna, 2022, v. 14, n. 4, p. 139
- By:
- Publication type:
- Article
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1398419
- By:
- Publication type:
- Article
A marginalized two‐part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 60, doi. 10.1002/pst.2338
- By:
- Publication type:
- Article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040499
- By:
- Publication type:
- Article
Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 85, doi. 10.1159/000512821
- By:
- Publication type:
- Article
Inference on tree‐structured subgroups with subgroup size and subgroup effect relationship in clinical trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 27, p. 5039, doi. 10.1002/sim.9900
- By:
- Publication type:
- Article
The potential effect of Schisandrin‐B combination with panitumumab in wild‐type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 5, p. 1, doi. 10.1002/jbt.23324
- By:
- Publication type:
- Article
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 12, p. 2621, doi. 10.1007/s00384-021-04002-9
- By:
- Publication type:
- Article
A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 12, p. 2197, doi. 10.1007/s00384-020-03693-w
- By:
- Publication type:
- Article
PAPULO-PUSTULAR FOLLICULAR ERUPTION DURING PANITUMUMAB TREATMENT OF COLON CANCER.
- Published in:
- Dermatovenerologia Journal, 2021, v. 66, n. 4, p. 25
- By:
- Publication type:
- Article
Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review.
- Published in:
- Diseases, 2024, v. 12, n. 4, p. 79, doi. 10.3390/diseases12040079
- By:
- Publication type:
- Article
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Recent advances in Monoclonal antibodies based formulation used in the management of CRC.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 324, doi. 10.47750/pnr.2022.13.S06.047
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2024
- Publication type:
- Correction Notice
Practical Notes on the Current ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer in Resource-Constrained Environments of Low- to Middle-Income Countries.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Curative resection after percutaneous drainage followed by preoperative panitumumab monotherapy for locally advanced sigmoid colon cancer with intra-abdominal abscess: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Multidisciplinary management of locally recurrent rectal cancer with carbon ion radiotherapy followed by prophylactic removal of the irradiated bowel: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
With metastatic colorectal cancer: A single center experience use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2022, v. 39, n. 4, p. 1112, doi. 10.52142/omujecm.39.4.34
- By:
- Publication type:
- Article
Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
- By:
- Publication type:
- Article
The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 6849, doi. 10.1007/s00432-023-04628-y
- By:
- Publication type:
- Article
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2681, doi. 10.1007/s00432-020-03257-z
- By:
- Publication type:
- Article
Erratum: Funding Acknowledgment.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 426, doi. 10.14744/cpr.2023.21931
- Publication type:
- Article
Miller Fisher Syndrome and Cavernous Sinus Thrombosis Caused by Sinusitis.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 424, doi. 10.14744/cpr.2023.43531
- By:
- Publication type:
- Article
Panitumumab Induced Paronychia and Trichomegaly.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 422, doi. 10.14744/etd.2023.78646
- By:
- Publication type:
- Article
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
- By:
- Publication type:
- Article
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1209, doi. 10.1093/oncolo/oyad210
- By:
- Publication type:
- Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
- By:
- Publication type:
- Article
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases--a phase II study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231600
- By:
- Publication type:
- Article
Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer .
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1138357
- By:
- Publication type:
- Article
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1147497
- Publication type:
- Article
Case report: Long-term survival in a patient with metastatic colorectal cancer treated with trifluridine/tipiracil in the third-line setting.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1112224
- By:
- Publication type:
- Article
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1084681
- By:
- Publication type:
- Article
A Patient with Transverse Colon Cancer Complicated by Cowden Syndrome Administered FOLFOXIRI + Bevacizumab Therapy.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00960-x
- By:
- Publication type:
- Article
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
- Published in:
- 2021
- By:
- Publication type:
- journal article
A service evaluation at the Singleton Hospital (Swansea Bay University Health Board); Swansea, UK to examine capacity use (chair and treatment time) for metastatic colorectal cancer patients (mCRC) treated with EGFR therapies and chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, p. 89, doi. 10.1177/10781552231153542
- By:
- Publication type:
- Article
Panitumumab Associated Acute Pancreatitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1207, doi. 10.1177/10781552221073997
- By:
- Publication type:
- Article
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86966-w
- By:
- Publication type:
- Article
Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027890
- By:
- Publication type:
- Article
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1015510
- By:
- Publication type:
- Article
Error in Text Wording and Incorrect Reference.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 24, p. 2196, doi. 10.1001/jama.2023.10533
- Publication type:
- Article
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 15, p. 1271, doi. 10.1001/jama.2023.4428
- By:
- Publication type:
- Article
Intravitreal panitumumab for prevention of myopic axial elongation in highly myopic adult eyes with myopic macular degeneration: Phase 1 study on safety.
- Published in:
- Acta Ophthalmologica (1755375X), 2022, v. 100, p. N.PAG, doi. 10.1111/j.1755-3768.2022.0240
- By:
- Publication type:
- Article
A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study.
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02140-6
- By:
- Publication type:
- Article
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1877, doi. 10.1007/s00262-021-03124-x
- By:
- Publication type:
- Article
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21582-w
- By:
- Publication type:
- Article